Mesoscopic Metal Nanoparticles Doubly Functionalized with Natural and Engineered Lipidic Dispersants for Therapeutics
Source abstract
Abstract
Surface engineering of mesoscopic metal nanoparticles to increase biocompatibility and cell interaction is important for improvement of their therapeutic properties. Here, we describe a strategy to stabilize mesoscopic metal nanoparticles and to enhance their cell interaction by stepwise addition of (Z)-9-octadecenoate (oleate) and a cell-penetrating peptide-fused high-density lipoprotein (cpHDL). Oleate replaces a cytotoxic dispersant on the surface of gold nanorods (AuNRs), which enables subsequent cpHDL binding without causing aggregation. Notably, these two lipidic dispersants are probably intercalated on the surface. This procedure was also used to stabilize 20 nm spherical gold nanoparticles and 40 nm aggregates of 10 nm magnetite nanoparticles. cpHDL-bound AuNRs were internalized greater than 80 times more efficiently than poly(ethylene glycol)-conjugated AuNRs and were able to elicit cancer cell photoablation.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Advanced biosensing and bioanalysis techniques · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute for Integrated Cell-Material Sciences (WPI-iCeMS), Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan
Department of Molecular Engineering, Graduate School of Engineering, Kyoto University, Nishikyo-ku, Kyoto 615-8510, Japan
Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan
References (37)
Show source-provided references
1. Melancon M. P. · Acc. Chem. Res. · 2011 · 44 · 94710.1021/ar200022e ↗
2. Jain K. K. · BMC Med. · 2010 · 8 · 8310.1186/1741-7015-8-83 ↗
3. Yu Y.-Y. · J. Phys. Chem. B · 1997 · 101 · 666110.1021/jp971656q ↗
4. Mohamed M. D. · J. Phys. Chem. B · 1998 · 102 · 937010.1021/jp9831482 ↗
5. Link S. · J. Phys. Chem. B · 1999 · 103 · 307310.1021/jp990183f ↗
6. Jain P. K. · J. Phys. Chem. B · 2006 · 110 · 723810.1021/jp057170o ↗
7. Bouhelier A. · Phys. Rev. Lett. · 2005 · 95 · 26740510.1103/PhysRevLett.95.267405 ↗
8. Huang X. · Nanomedicine (London, U. K.) · 2007 · 2 · 68110.2217/17435889.2.5.681 ↗
9. Tong L. · Photochem. Photobiol. · 2009 · 85 · 2110.1111/j.1751-1097.2008.00507.x ↗
10. Alkilany A. M. · Small · 2009 · 5 · 70110.1002/smll.200801546 ↗
11. Niidome T. · J. Controlled Release · 2006 · 114 · 34310.1016/j.jconrel.2006.06.017 ↗
12. Prencipe G. · J. Am. Chem. Soc. · 2009 · 131 · 478310.1021/ja809086q ↗
13. Von Maltzahn G. · Cancer Res. · 2009 · 69 · 389210.1158/0008-5472.CAN-08-4242 ↗
14. Bonoiu A. C. · Nanomedicine (London, U. K.) · 2011 · 6 · 61710.2217/nnm.11.20 ↗
15. Chakravarthy K. V. · Proc. Natl. Acad. Sci. U.S.A. · 2010 · 107 · 1017210.1073/pnas.0914561107 ↗
16. Lee S. E. · Nano Lett. · 2009 · 9 · 56210.1021/nl802689k ↗
17. Huang X. · J. Am. Chem. Soc. · 2006 · 128 · 211510.1021/ja057254a ↗
18. Alkilany A. · Small · 2012 · 8 · 127010.1002/smll.201101948 ↗
19. Huff T. B. · Langmuir · 2007 · 23 · 159610.1021/la062642r ↗
20. Stefanick J. F. · ACS Nano · 2013 · 7 · 293510.1021/nn305663e ↗
21. Enselme J. · 1969
22. Lund-Katz S. · 2010 · 18310.1007/978-90-481-8622-8_7 ↗
23. Murakami T. · Nanomedicine (London, U. K.) · 2010 · 5 · 86710.2217/nnm.10.66 ↗
24. Chauhan A. · J. Controlled Release · 2007 · 117 · 14810.1016/j.jconrel.2006.10.031 ↗
25. Palm-Apergi C. · Mol. Ther. · 2012 · 20 · 69510.1038/mt.2012.40 ↗
26. Murakami T. · Mol. BioSyst. · 2010 · 6 · 78910.1039/c001442g ↗
27. Nikoobakht B. · Langmuir · 2001 · 17 · 636810.1021/la010530o ↗
28. Hubert F. · Langmuir · 2008 · 24 · 921910.1021/la801711q ↗
29. Murphy C. J. · Chem. Commun. · 2008 · 54410.1039/B711069C ↗
30. Chandra S. · Adv. Drug Delivery Rev. · 2011 · 63 · 126710.1016/j.addr.2011.06.003 ↗
31. Cormode D. P. · Nano Lett. · 2008 · 8 · 371510.1021/nl801958b ↗
32. Thaxton C. S. · J. Am. Chem. Soc. · 2009 · 131 · 138410.1021/ja808856z ↗
33. Gerweck L. E. · Cancer Res. · 1985 · 45 · 3408
34. Matz C. E. · J. Biol. Chem. · 1982 · 257 · 453510.1016/S0021-9258(18)34756-2 ↗
35. Numata T. · J. Am. Chem. Soc. · 2012 · 134 · 609210.1021/ja3007275 ↗
36. Takata K. · J. Lipid Res. · 1988 · 29 · 111710.1016/S0022-2275(20)38447-9 ↗
37. de la Fuente J. M. · Bioconjugate Chem. · 2005 · 16 · 117610.1021/bc050033+ ↗